• Mapping GCGR Small Molecule Binding Sites via Dynamics and C

  2026-06-02

  This study leverages crystal structure data and molecular dynamics simulations to systematically identify and characterize small molecule binding sites on the glucagon receptor (GCGR), with MK 0893 serving as a structural benchmark. The findings provide mechanistic insight for rational antagonist design, informing type 2 diabetes research and drug development.

• U-73122: Potent Phospholipase C Inhibitor for Signal Pathway

  2026-06-02

  U-73122 is a selective phospholipase C inhibitor widely used for dissecting PLC signaling and calcium flux in cellular models. Its potency and specificity enable precise modulation of chemotaxis and inflammation, with robust in vitro and in vivo benchmarks. This product is supplied by APExBIO for research use only.

• BFH772 (VEGFR2 inhibitor): Technical Use & Workflow Guidance

  2026-06-01

  BFH772 is a highly selective VEGFR2 inhibitor designed for precise inhibition of VEGFR2-driven angiogenesis, making it suitable for tumor angiogenesis and related pathway research where high kinase selectivity and organic solvent compatibility are required. It should not be used in protocols that demand water solubility or broad-spectrum kinase inhibition.

• Cy5 Maleimide (Non-sulfonated): Illuminating Electrostatic P

  2026-06-01

  Explore how Cy5 maleimide (non-sulfonated) enables next-generation protein labeling by probing biomolecular electrostatics and phase separation. This in-depth guide unlocks new assay strategies beyond conventional protocols, positioning APExBIO’s dye at the frontier of fluorescence research.

• Phosphoenolpyruvate Restricts cGAS-Driven Inflammation in Ag

  2026-05-31

  This study reveals that phosphoenolpyruvate (PEP), a glycolytic metabolite, acts as an adaptive inhibitor of cGAS–STING-mediated inflammation, mitigating age-related functional decline. By delineating the biphasic trajectory of PEP during aging and its mechanistic role in controlling chronic inflammation, the findings open new avenues for metabolic interventions in healthy aging and neurodegenerative disease models.

• Minoxidil Sulphate: Unveiling Vascular K+ Channel Dynamics i

  2026-05-30

  Discover how Minoxidil sulphate empowers advanced vascular biology and hair growth research by elucidating K+ channel mechanisms. This article delivers a unique, evidence-driven perspective for experimental design and translational insight.

• Bone Transport Boosts Diabetic Foot Healing via TGF-β1 Pathw

  2026-05-29

  This study reveals that bone transport surgery significantly accelerates diabetic foot ulcer (DFU) healing by activating TGF-β1-mediated angiogenic and osteo-immune coupling. The findings clarify how the TGF-β1/TGFBR1 signaling axis bridges bone regeneration, vascularization, and immune modulation in chronic wound repair, suggesting new therapeutic avenues targeting this pathway.

• Hexa-Acylated Gut LPS Enhances Anti-PD-1 Cancer Immunotherap

  2026-05-29

  This study demonstrates that specific hexa-acylated lipopolysaccharides (LPS) produced by gut microbiota enhance the efficacy of anti-PD-1 immunotherapy in cancer. By functionally profiling patient microbiomes and using in vivo mouse models, the authors reveal that LPS structure—not simply bacterial species—critically modulates immune checkpoint inhibitor response, suggesting new biomarkers and cautioning against indiscriminate use of LPS-blocking interventions.

• Toremifene Citrate: Applied Workflows in Breast Cancer Resea

  2026-05-28

  Toremifene Citrate, a high-affinity oral selective estrogen receptor modulator, is a gold-standard tool for dissecting estrogen receptor signaling in breast cancer research. This article offers practical guidance on optimized experimental workflows, troubleshooting, and protocol parameters—empowering research teams to maximize data quality using APExBIO’s rigorously validated reagent.

• Hesperadin: Mechanistic Insights and Assay Strategies for Au

  2026-05-28

  Explore how Hesperadin, a leading Aurora B kinase inhibitor, enables precise dissection of mitotic regulation and spindle assembly checkpoint dynamics. This in-depth analysis uniquely connects mechanistic action with advanced assay design, offering researchers critical guidance beyond standard applications.

• GRK Subtype Bias in M1 Receptor Signaling: Mechanistic Insig

  2026-05-27

  This study reveals how distinct GRK subtypes differentially regulate M1 muscarinic acetylcholine receptor (mAChR) signaling bias, dissecting the dynamic interplay between M1, G proteins, and β-arrestin using high-sensitivity BRET assays. The findings clarify the molecular mechanisms by which modulators like BQCA enhance cognitive signaling pathways, with implications for optimizing Alzheimer’s disease research.

• FOXM1–ERα ceRNA Network as a Biomarker Axis in Female LUAD

  2026-05-27

  This study delineates a novel ceRNA network centered on FOXM1 and estrogen receptor alpha (ERα) in female lung adenocarcinoma (LUAD), integrating multi-omics analyses and cellular validation. The findings highlight the prognostic and therapeutic relevance of FOXM1–ERα interactions, offering mechanistic insight into estrogen receptor signaling in lung cancer.

• Miltefosine Promotes Neutrophil Differentiation via Ras/MEK/

  2026-05-26

  The referenced study establishes that miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) activates the Ras/MEK/ERK signaling cascade, driving neutrophil differentiation and restoring hematopoiesis in leukopenia models. These findings identify a new mechanistic framework for repurposing miltefosine in hematology and provide actionable insight for translational immune recovery research.

• PEI-Laminarin Nanoparticles Enhance Vaccine Immunity via Lys

  2026-05-26

  The reference study introduces polyethyleneimine-modified laminarin nanoparticles (CLam/OVA) as a novel vaccine adjuvant that significantly boosts both humoral and cellular immune responses compared to traditional aluminum adjuvants. The findings underscore the importance of nanoparticle charge and functionalization for antigen delivery and cross-presentation, with direct implications for the design of advanced nanovaccine platforms.

• Midecamycin: Applied Protocols for Antibacterial Assays

  2026-05-25

  Midecamycin, an acetoxy-substituted macrolide antibiotic, empowers researchers to dissect Gram-positive bacterial inhibition with reproducible, data-driven workflows. This guide translates bench-tested findings into practical experimental setups, troubleshooting tips, and comparative insights for advanced antibacterial research.

550 records 16/37 page Previous Next First page 上5页 1617181920 下5页 Last page